Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
What classes of drugs are used to tx CHF? (broadly)
|
Positive inotropic drugs
Diuretics ACE inhibs and Angiotensin blockers Vasodilators |
|
What are the 3 classes of positive inotropic drugs?
|
cardiac glycosides (digitalis)
Bipyridines (inamrinone, milrinone) Sympathomimetics (dobutamine, dopamine) |
|
Two ACE inhibs used to tx CHF?
|
captopril
lisinopril |
|
Two angiotensin receptor blockers used to tx CHF?
|
losartan
candesartan |
|
What's the basic difficulty in heart failure?
|
Weakened contractile force
|
|
How does a failing heart compensate for it's impaired contractility?
|
Increasing rate and size of heart and activating the renin-angiotensin system
|
|
Name 6 consequences of heart failure.
|
Increased pressure in main circuits (inc venous pressure/pulmonary pressure).
Dyspnea Cyanosis Edema Increased Heart Rate Increased Heart Size |
|
Name 4 symptoms of heart failure.
|
1. tachycardia
2. dec exercise tolerance 3. shortness of breath 4. peripheral and pulmonary edema |
|
What are the major causes of left heart failure? (4)
|
coronary artery disease
hypertension valvular myocardial infarction |
|
What are the major causes of right heart failure? (4)
|
secondary to left-sided failure
pulmonary emphysema pulmonary valve lesions tricuspid valve stenosis or insuffieciency |
|
Biochem explanations for the impaired contractility seen in heart failure? (6)
|
1. ↓ rate of Ca binding by SR
2. ↓ intracell levels of cyclic AMP 3. ↓ β-receptor density or coupling 4. ↓ Na/Ca exchange 5. ↓ content of myofibibrillar protein 6. ↓activity of actomyosin and/or myosin ATPase |
|
What are the stages of heart failure?
|
Asymptomatic dysfunction, compensated, decompensated, and refractory (sx not controlled with tx)
|
|
Structural features of cardiac glycosides?
|
a. Steroidal nucleus
b. Unsaturated lactone ring on C17 c. Combination of aglycone with 1 to 4 molecules of sugar via a glycoside linkage at C3. |
|
Effects of Cardiac Glycosides on...inotropy? Excitability? Conduction Velocity?
|
Inotropy: Positive (↑C.O. = ↓sx CHF).
Excitability: slight ↑ A>Ven Conduction Velocity: slightly ↑ in atria & ventricle/significantly ↓ in conducting tissue esp. A-V node and His-Purkinje System |
|
Effects of Cardiac Glycosides on...Refractory Period? Automaticity? Heart Rate?
|
Refractory Period: slightly ↑ in atria & nodal tissue/slightly ↓ in ventricles
Automaticity: can be greatly ↑ (esp ventricle) Heart Rate: ↓ due to vagal stimulation and, in CHF, improved hemodynamics |
|
Effects of Cardiac Glycosides on...BP? Diuresis? (why?)
|
BP: not important in CHF tx; ↑ PVR due to vasoconstrict.
Diuresis: slight ↑ primarily due to ↑ renal blood flow as a consequence of positive inotropic effect (↑ CO etc.) |
|
Mechanism of action of Cardiac Glycosides?
|
interacts with membrane-bound Na+-K+ ATPase (Na-K pump).
|
|
Therapeutic uses of Cardiac Glycosides?
|
1. CHF
2. CHF with by atrial fibrillation 3. Supraventricular arrhythmias |
|
Toxicity of Cardiac Glycosides?
|
Very narrow therapeutic index. Estimated that it requires 60% of the toxic dose for therapeutic effectiveness
|
|
Early toxic symptoms of Cardiac Glycosides?
|
distaste for food, nausea, vomiting, diarrhea, disturbance of vision. (nausea and vomiting are due to a central effect)
|
|
Late toxic symptoms of Cardiac Glycosides?
|
complete spectrum of cardiac arrhythmias may result including A-V block, vent extrasystoles and vent fibrillation
|
|
What enhances the toxicity of Cardiac Glycosides?
|
Hypokalemia
|
|
How is severe glycoside toxicity treated?
|
Cardiac pacemaker catheritization
Administration of digitalis antibodies |
|
What's the onset of action, max effect and action regression times of digoxin?
|
10-30min onset
1-5 hr max effect 10 hr regression (35 hr half life) 2-6 days action gone |
|
What percent of digoxin is absorbed, what percent is bound to plasma proteins, and what percent is excreted daily?
|
75% absorbed via GI
25% bound 30% excreted daily (renal) |
|
Name 2 bipyridines. Route?
|
Inamrinone
Milrinone Given IV |
|
How do bipyridines work?
|
Selective inhibitors of phosphodiesterase 3 that reduce cAMP degradation = direct stimulation of myocardial contractility and vessel dilation = decreased PVR and pulmonary resistance
|
|
What are dobutamine and dopamine? What do they do?
|
Beta agonists.
Both increase force of contraction. Dopamine also increases RBF. |
|
What are the disadvantages of dobutamine and dopamine?
|
Must be given IV
Tolerance can develop |
|
What is the major benefit of diuretics in the tx of CHF?
|
Counters increased sodium & water retention
Effects are additive with those of ACE inhibitors & β antagonists |
|
What is the use of ACE inhibitors and angiotensin blockers in the tx of CHF?
|
Counter increased sodium & water retention due to activation of the renin-angiotensin-aldosterone system associated with CHF
|
|
What do ACE inhibitors do?
|
Suppress Ang II and aldosterone production, decrease sympathetic nervous system activity, and potentiate the effects of diuretics
|
|
Which vessels do ACE inhibitors work best on? What's the effect of this?
|
Arteries
Reduces afterload = increased stroke volume and cardiac output |
|
What's the effect of ACE inhibitors in CHF pts with reduced renal blood flow?
|
They limit the kidney’s ability to regulate glomerular perfusion pressure due to their selective effects on efferent arterial tone
|
|
What common precipitating event for CHF are ACE inhibitors useful for?
|
MI is the leading cause of CHF. ACE inhibs reduce vent dysfunction and mortality after acute MI = may prevent adverse ventricular remodeling
|
|
What does Hydralazine do?
|
Causes direct relaxation of arterial smooth muscle and reduces right & left ventricular afterload by reducing pulmonary and systemic vascular resistance
|
|
When is Hydralazine particularly useful in the tx of CHF?
|
CHF patients with renal dysfunction who can not tolerate ACE inhibitors
|
|
When is Hydralazine most effective?
|
when combined with venodilating agents (eg. organic nitrates)
|
|
How are β-Adrenergic blockers useful in the tx of CHF?
|
May antagonize the sustained activation of sympathetic nerves in compensated CHF may contribute to the progression of contractile dysfunction
β-blockers have shown to reduce hospitalization and decrease mortality in patients with mild-to-moderate CHF. |
|
What tx is recommended in stage A CHF? (high risk, no sx)
|
Risk factor reduction
Education |
|
What tx is recommended in stage B CHF? (structural disease, no sx)
|
ACE inhibs or angiotensin 1 receptor blockers for all pts
Beta blockers for some |
|
What tx is recommended in stage C CHF? (sx)
|
ACE inhibs and beta blockers in all pts
|
|
What tx is recommended in stage D CHF? (refractory sx)
|
inotropes
|